INS and Hyperglycemia: Although the currently available therapeutic regimens can ameliorate hyperglycemia or temporarily improve insulin sensitivity in target tissues, these can neither reverse insulin resistance nor the progressive and inexorable beta cell dysfunction [7]; that is, none of these therapies modulate the course of the disease.